Evotec SE – SIX:EVT.SW
Evotec SE stock price today
Evotec SE key metrics
Market Cap | 4.77B |
Enterprise value | 4.79B |
P/E | -25.92 |
EV/Sales | 7.14 |
EV/EBITDA | 285.78 |
Price/Sales | 7.10 |
Price/Book | 3.87 |
PEG ratio | N/A |
EPS | -0.51 |
Revenue | 776.59M |
EBITDA | -74.54M |
Income | -90.68M |
Revenue Q/Q | -2.26% |
Revenue Y/Y | -2.96% |
Profit margin | -2.12% |
Oper. margin | 0.13% |
Gross margin | 20.1% |
EBIT margin | 0.13% |
EBITDA margin | -9.6% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEvotec SE stock price history
Evotec SE stock forecast
Evotec SE financial statements
| Jun 2023 | 170.27M | -14.92M | -8.77% |
|---|---|---|---|
| Sep 2023 | 196.27M | -38.95M | -19.85% |
| Dec 2023 | 201.31M | -16.13M | -8.01% |
| Mar 2024 | 208.72M | -20.67M | -9.9% |
| Jun 2023 | 2301221000 | 1.12B | 48.97% |
|---|---|---|---|
| Sep 2023 | 2254509000 | 1.11B | 49.4% |
| Dec 2023 | 2299053000 | 1.17B | 51.29% |
| Mar 2024 | 2208650000 | 1.10B | 49.9% |
| Jun 2023 | -6.20M | 33.44M | 13.95M |
|---|---|---|---|
| Sep 2023 | 20.75M | -15.76M | 43.36M |
| Dec 2023 | 18.76M | -36.68M | 30.96M |
| Mar 2024 | -47.19M | -31.97M | -5.78M |
Evotec SE alternative data
| Aug 2023 | 4,952 |
|---|---|
| Sep 2023 | 5,067 |
| Oct 2023 | 5,067 |
| Nov 2023 | 5,067 |
| Dec 2023 | 5,086 |
| Jan 2024 | 5,086 |
| Feb 2024 | 5,086 |
| Mar 2024 | 5,086 |
| Apr 2024 | 5,086 |
| May 2024 | 5,061 |
| Jun 2024 | 5,055 |
| Jul 2024 | 5,055 |
Evotec SE other data
-
What's the price of Evotec SE stock today?
One share of Evotec SE stock can currently be purchased for approximately $26.96.
-
When is Evotec SE's next earnings date?
Unfortunately, Evotec SE's (EVT.SW) next earnings date is currently unknown.
-
Does Evotec SE pay dividends?
No, Evotec SE does not pay dividends.
-
How much money does Evotec SE make?
Evotec SE has a market capitalization of 4.77B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.99% to 781.43M US dollars.
-
What is Evotec SE's stock symbol?
Evotec SE is traded on the SIX under the ticker symbol "EVT.SW".
-
What is Evotec SE's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Evotec SE?
Shares of Evotec SE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Evotec SE have?
As Jul 2024, Evotec SE employs 5,055 workers, which is 1% less then previous quarter.
-
When Evotec SE went public?
Evotec SE is publicly traded company for more then 10 years since IPO on 4 Nov 2014.
-
What is Evotec SE's official website?
The official website for Evotec SE is evotec.com.
-
How can i contact Evotec SE?
Evotec SE can be reached via phone at +49 40 560810.
Evotec SE company profile:
Evotec SE
evotec.comSIX
5,055
Drug Manufacturers - Specialty & Generic
Healthcare
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Hamburg, 22419
:
ISIN: DE0005664809
:
